Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 3/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 1/20 | 1.00 |
| ▸ | DRD3 | P35462 | 1/20 | 1.00 |
| ▸ | OPRD1 | P41143 | 1/20 | 1.00 |
| ▸ | BCHE | P06276 | 15/20 | 0.65 |
| ▸ | ACHE | P22303 | 1/20 | 0.65 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | FDFT1 | P37268 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tianeptine SCHEMBL29877330 | 1.00 | NR1I2 (1.00) | NR1I2OPRM1DRD3OPRD1BCHE | |
| Tianeptine SCHEMBL3996165 | 1.00 | NR1I2 (1.00) | NR1I2OPRM1DRD3OPRD1BCHE | |
| Tianeptine SCHEMBL29470274 | 1.00 | NR1I2 (1.00) | NR1I2OPRM1DRD3OPRD1BCHE | |
| Tianeptine SCHEMBL29930593 | 1.00 | NR1I2 (1.00) | NR1I2OPRM1DRD3OPRD1BCHE | |
| Tianeptine SCHEMBL2894680 | 0.99 | NR1I2 (0.98) | NR1I2OPRM1DRD3OPRD1BCHE | |
| Tianeptine SCHEMBL1231001 | 0.99 | NR1I2 (0.98) | NR1I2OPRM1DRD3OPRD1BCHE | |
| Tianeptine SCHEMBL2897771 | 0.99 | NR1I2 (0.98) | NR1I2OPRM1DRD3OPRD1BCHE | |
| SCHEMBL4262606 | 0.99 | NR1I2 (0.98) | NR1I2OPRM1DRD3OPRD1BCHE | |
| Tianeptine SCHEMBL20338621 | 0.98 | NR1I2 (0.96) | NR1I2OPRM1DRD3OPRD1BCHE | |
| Hydrochloric Acid SCHEMBL22664293 | 0.98 | NR1I2 (0.96) | NR1I2OPRM1DRD3OPRD1BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6034 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12564597-B2 | Ibogaine analogs as therapeutics for neurological and psychiatric disorders | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE OF NEW YORK (US) | 2026-03-03 | — | — | US | claimed |
| EP-4688761-A1 | (S)-TIANEPTINE AND USE IN TREATING DISORDERS AND CONDITIONS ASSOCIATED WITH PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR | Tonix Pharma Limited (IE) | 2026-02-11 | — | — | EP | claimed |
| EP-3507371-B1 | COMPOSITIONS FOR TREATING DISEASES AND DISORDERS OF THE NERVOUS SYSTEM | UNIV RUTGERS (US) | 2026-01-28 | — | — | EP | claimed |
| EP-4680203-A1 | COMPOSITIONS FOR SUSTAINED RELEASE OF POORLY SOLUBLE ACTIVE INGREDIENTS | Prolevi Bio AB (SE) | 2026-01-21 | — | — | EP | claimed |
| US-20260001942-A1 | TREATMENT OF HEADACHE DISORDERS AND/OR PSYCHIATRIC SYMPTOMS USING ANTI-CGRP ANTIBODIES, AND COMPOSITIONS AND METHODS RELATED THERETO | H LUNDBECK AS (DK) | 2026-01-01 | — | — | US | claimed |
| WO-2025262247-A1 | TREATMENT OF HEADACHE DISORDERS AND/OR PSYCHIATRIC SYMPTOMS USING ANTI-CGRP ANTIBODIES, AND COMPOSITIONS AND METHODS RELATED THERETO | H. LUNDBECK A/S (DK) | 2025-12-26 | — | — | WO | claimed |
| US-20250312293-A1 | ESKETAMINE FOR USE IN TREATING MAJOR DEPRESSIVE DISORDER | CLEXIO BIOSCIENCES LTD (IL) | 2025-10-09 | — | — | US | claimed |
| US-20250295674-A1 | NEUROACTIVE STEROIDS FOR TREATMENT OF CNS-RELATED DISORDERS | SAGE THERAPEUTICS, INC. | 2025-09-25 | — | — | US | claimed |
| US-20250195454-A1 | METHOD OF TREATING MAJOR DEPRESSIVE DISORDER | CLEXIO BIOSCIENCES LTD. (IL) | 2025-06-19 | — | — | US | claimed |
| US-20250177418-A1 | NEUROACTIVE STEROIDS FOR TREATMENT OF GASTROINTESTINAL DISEASES OR CONDITIONS | SAGE THERAPEUTICS, INC. | 2025-06-05 | — | — | US | claimed |
| US-5888542-A | ANTIDEPRESSANT | ADIR ET COMPAGNIE (FR) | 1999-03-30 | — | — | US | claimed |
| WO-1998022114-A1 | A METHOD FOR PROMOTING TISSUE REPAIR | DUMEX-ALPHARMA A/S (DK) | 1998-05-28 | — | — | WO | claimed |
| WO-1998019096-A1 | IMPROVED PINCH CLAMP | MIKALOR S.A. (ES) | 1998-05-07 | — | — | WO | claimed |
| CN-1168792-A | Matrix table allowing prolonged release of sodium salt of tianeptine after administration by oral route | ADIR (FR) | 1997-12-31 | — | — | CN | claimed |
| EP-0803253-A1 | Matrix-type oral sustained-release tablets containing tianeptine sodium salt | ADIR ET COMPAGNIE (FR) | 1997-10-29 | — | — | EP | claimed |
| US-4970927-A | Method and apparatus for the cutting of panels or packs of panels by the use of a single disc-saw | GIBEN IMPIANTI S.P.A. (IT) | 1990-11-20 | — | — | US | claimed |
| EP-0343561-A2 | Controlled impedance connector assembly | Burndy Corporation (US) | 1989-11-29 | — | — | EP | claimed |
| EP-0260211-A2 | An automatic inflation and pressure control device for the tyres of motor vehicles with air compressors | Oglio, Carlos G. (ES) | 1988-03-16 | — | — | EP | claimed |
| US-4052622-A | CHILD'S LAMP AND AUDIO DEVICE | LORENZ MICHAEL | 1977-10-04 | — | — | US | claimed |
| US-3994421-A | Unitary therapeutic aerosol dispenser | AMERICAN CYANAMID COMPANY (US) | 1976-11-30 | — | — | US | claimed |